Renalgan
General properties
Antispasmodics in combination with analgesics.
Symptomatic treatment of pain with spasms of smooth muscles of internal organs:
- stomach and intestinal cramps;
- renal colic with nephrolithiasis;
- spastic dyskinesia of the biliary tract;
- dysmenorrhea.
Hypersensitivity to the drug, to pyrazolone derivatives (phenylbutazone, tribuzon) or other non-steroidal anti-inflammatory drugs (NSAIDs). Severe liver or kidney failure, megacolon, acute hepatic porphyria, a suspicion of surgical pathology, prostate adenoma II and III degree, a congenital deficiency of glucose-6-phosphate dehydrogenase, tachyarrhythmia, closure type of glaucoma, prostatic hypertrophy with tendency to urinary retention, obstruction of the gastrointestinal tract (including mechanical obstruction), or atony of the gall bladder, disorders of the hematopoietic system (agranulocytosis, leukopenia, aplastic anemia), collaptoid states, decompensated heart failure, asthma, hemolytic anemia.
Pharmaceutical characteristics
Clear liquid of light-yellow color with slight greenish tint.
Keep out of reach of children in original packaging at temperature not exceeding 25 °С.